Boston Scientific Corporation

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 11:44:05 2024-05-15 am EDT			5-day change	1st Jan Change
74.26 ^USD	+1.05%		+2.15%	+28.49%

12:16pm	Mizuho Adjusts Price Target on Boston Scientific to $90 From $85, Keeps Buy Rating	MT
May. 14	Transcript : Boston Scientific Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM

Amaranth Medical, Inc. announced that it has received funding from Boston Scientific Corporation.

January 13, 2014 at 11:00 pm EST

Amaranth Medical, Inc. announced that it has received its series C round of equity funding from new investor, Boston Scientific Corporation on January 14, 2014. The terms of the transaction were not disclosed.

On January 14, 2014, Amaranth Medical, Inc. closed the transaction.

Latest news about Boston Scientific Corporation

Mizuho Adjusts Price Target on Boston Scientific to $90 From $85, Keeps Buy Rating	06:16am	MT
Transcript : Boston Scientific Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM	May. 14
Boston Scientific Insider Sold Shares Worth $958,717, According to a Recent SEC Filing	May. 13	MT
Boston Scientific Insider Sold Shares Worth $286,874, According to a Recent SEC Filing	May. 08	MT
Boston Scientific Corporation Appoints Cheryl Pegus to its Board of Directors	May. 08	CI
Boston Scientific Insider Sold Shares Worth $1,257,488, According to a Recent SEC Filing	May. 02	MT
Boston Scientific Insider Sold Shares Worth $499,075, According to a Recent SEC Filing	May. 02	MT
Boston Scientific Insider Sold Shares Worth $719,562, According to a Recent SEC Filing	Apr. 29	MT
Daiwa Adjusts Price Target on Boston Scientific to $81 From $73	Apr. 26	MT
Redburn Atlantic Adjusts Price Target on Boston Scientific to $79 From $75	Apr. 26	MT
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength	Apr. 25	RE
UBS Raises Boston Scientific's Price Target to $90 From $74, Maintains Buy Rating	Apr. 25	MT
Oppenheimer Adjusts Boston Scientific's Price Target to $77 From $68	Apr. 25	MT
Bernstein Adjusts Boston Scientific Price Target to $86 From $75	Apr. 25	MT
Deutsche Bank Adjusts Price Target on Boston Scientific to $73 From $63	Apr. 25	MT
Baird Adjusts Price Target on Boston Scientific to $84 From $79	Apr. 25	MT
JPMorgan Adjusts Price Target on Boston Scientific to $82 From $72	Apr. 25	MT
Raymond James Adjusts Boston Scientific Price Target to $85 From $73	Apr. 25	MT
Wolfe Research Adjusts Boston Scientific Price Target to $81 From $72	Apr. 25	MT
CL King Adjusts Boston Scientific's Price Target to $82 From $72	Apr. 25	MT
Canaccord Genuity Adjusts Price Target on Boston Scientific to $83 From $81	Apr. 25	MT
Barclays Adjusts Boston Scientific's Price Target to $78 From $70	Apr. 25	MT
Wells Fargo Adjusts Price Target on Boston Scientific to $82 From $72	Apr. 25	MT
Truist Raises Price Target on Boston Scientific to $86 From $79, Keeps Buy Rating	Apr. 25	MT
Needham Adjusts Price Target on Boston Scientific to $82 From $71	Apr. 25	MT

Chart Boston Scientific Corporation

Duration

Period

More charts

Company Profile

Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-29 - Bernstein Strategic Decisions Conference

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Boston Scientific Corporation

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

73.49 USD

Average target price

81.16 USD

Spread / Average Target

+10.44%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
BOSTON SCIENTIFIC CORPORATION	+28.49%	108B
THERMO FISHER SCIENTIFIC	+12.63%	227B
DANAHER CORPORATION	+13.48%	192B
INTUITIVE SURGICAL, INC.	+17.33%	136B
SIEMENS HEALTHINEERS AG	+1.60%	64.07B
EDWARDS LIFESCIENCES CORPORATION	+17.34%	52.1B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+7.04%	51.87B
AGILENT TECHNOLOGIES, INC.	+10.39%	44.33B
GE HEALTHCARE TECHNOLOGIES INC.	+4.77%	36.75B
RESMED, INC.	+27.74%	31.71B

Other Advanced Medical Equipment & Technology